Modes of Action and Species-Specific Effects of Di-(2-ethylhexyl)Phthalate in the Liver
Open accessThe DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Abstract
The industrial plasticizer di-(2-ethylhexyl)phthalate (DEHP) is used in manufacturing of a wide variety of polyvinyl chloride (PVC)-containing medical and consumer products. DEHP belongs to a class of chemicals known as peroxisome proliferators (PPs). PPs are a structurally diverse group of compounds that share many (but perhaps not all) biological effects and are characterized as non-genotoxic rodent carcinogens. This review focuses on the effect of DEHP in liver, a primary target organ for the pleiotropic effects of DEHP and other PPs. Specifically, liver parenchymal cells, identified herein as hepatocytes, are a major cell type that are responsive to exposure to PPs, including DEHP; however, other cell types in the liver may also play a role. The PP-induced increase in the number and size of peroxisomes in hepatocytes, so called 'peroxisome proliferation' that results in elevation of fatty acid metabolism, is a hallmark response to these compounds in the liver. A link between peroxisome proliferation and tumor formation has been a predominant, albeit questioned, theory to explain the cause of a hepatocarcinogenic effect of PPs. Other molecular events, such as induction of cell proliferation, decreased apoptosis, oxidative DNA damage, and selective clonal expansion of the initiated cells have been also been proposed to be critically involved in PP-induced carcinogenesis in liver. Considerable differences in the metabolism and molecular changes induced by DEHP in the liver, most predominantly the activation of the nuclear receptor peroxisome proliferator-activated receptor (PPAR)alpha, have been identified between species. Both sexes of rats and mice develop adenomas and carcinomas after prolonged feeding with DEHP; however, limited DEHP-specific human data are available, even though exposure to DEHP and other phthalates is common in the general population. This likely constitutes the largest gap in our knowledge on the potential for DEHP to cause liver cancer in humans. Overall, it is believed that the sequence of key events that are relevant to DEHP-induced liver carcinogenesis in rodents involves the following events whereby the combination of the molecular signals and multiple pathways, rather than a single hallmark event (such as induction of PPARalpha and peroxisomal genes, or cell proliferation) contribute to the formation of tumors: (i) rapid metabolism of the parental compound to primary and secondary bioactive metabolites that are readily absorbed and distributed throughout the body; (ii) receptor-independent activation of hepatic macrophages and production of oxidants; (iii) activation of PPARalpha in hepatocytes and sustained increase in expression of peroxisomal and non-peroxisomal metabolism-related genes; (iv) enlargement of many hepatocellular organelles (peroxisomes, mitochondria, etc.); (v) rapid but transient increase in cell proliferation, and a decrease in apoptosis; (vi) sustained hepatomegaly; (vii) chronic low-level oxidative stress and accumulation of DNA damage; (viii) selective clonal expansion of the initiated cells; (ix) appearance of the pre-neoplastic nodules; (x) development of adenomas and carcinomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519 · cited 3×
“A discovery of a family of the nuclear receptors, peroxisome proliferator-activated receptors (PPARs) (Issemann and Green, 1990), shed light on the mechanism of action of PP compounds, as well as opened new opportunities for therapeutic interventions in many human diseases (Berger et al., 2005).”
BackgroundPeroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
The Role of Oxidative Stress in Carcinogenesis
Klaunig, J. E., & Kamendulis, L. M. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121851 · Cited by 1,533
Peroxisome proliferator-activated receptor a target genes
Mandard, S., M�ller, M., & Kersten, S. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3216-3 · Cited by 1,218
Kasai, H. (1997) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(97)00035-5 · Cited by 1,139
Biologically active products of stimulated liver macrophages (Kupffer cells)
DECKER, K. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb19222.x · Cited by 904
Aoyama, T., Peters, J. M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T., & Gonzalez, F. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5678 · Cited by 863
Self-citationHypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens
Reddy, J. K., Azarnoff, D. L., & Hignite, C. E. (1980) · Nature · doi:10.1038/283397a0 · Cited by 837
PPARs: therapeutic targets for metabolic disease
Berger, J. P., Akiyama, T. E., & Meinke, P. T. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.003 · Cited by 713
Levels of Seven Urinary Phthalate Metabolites in a Human Reference Population
Blount, B. C., Silva, M. J., Caudill, S. P., Needham, L. L., Pirkle, J. L., Sampson, E. J., Lucier, G. W., Jackson, R. J., & Brock, J. W. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108979 · Cited by 634 · cited 1×
“For example, the concentration of urinary MEHP ranged from undetectable levels up to 66.6 ng/mL, with an average concentration of 3.5 ng/mL (Blount et al., 2000).”
BackgroundInfluentialKavlock, R., Boekelheide, K., Chapin, R., Cunningham, M., Faustman, E., Foster, P., Golub, M., Henderson, R., Hinberg, I., Little, R., et al. (2002) · Reproductive Toxicology · doi:10.1016/s0890-6238(02)00032-1 · Cited by 633
Self-citationPPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance
Klaunig, J. E., Babich, M. A., Baetcke, K. P., Cook, J. C., Corton, J. C., David, R. M., DeLuca, J. G., Lai, D. Y., McKee, R. H., Peters, J. M., et al. (2003) · Critical Reviews in Toxicology · doi:10.1080/713608372 · Cited by 611
Self-citationGulick, T., Cresci, S., Caira, T., Moore, D. D., & Kelly, D. P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11012 · Cited by 560
Sher, T., Yi, H. F., McBride, O. W., & Gonzalez, F. J. (1993) · Biochemistry · doi:10.1021/bi00072a015 · Cited by 519
The role of oxidative stress in chemical carcinogenesis.
Klaunig, J. E., Xu, Y., Isenberg, J. S., Bachowski, S., Kolaja, K. L., Jiang, J., Stevenson, D. E., & Walborg, E. F. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.98106s1289 · Cited by 511
Activation of PPAR and PPAR by Environmental Phthalate Monoesters
Hurst, C. H., & Waxman, D. J. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg145 · Cited by 510
Peters, J. (1997) · Carcinogenesis · doi:10.1093/carcin/18.11.2029 · Cited by 479
Self-citationPeroxisome proliferator activated receptor-alpha expression in human liver.
Palmer, C. N., Hsu, M. H., Griffin, K. J., Raucy, J. L., & Johnson, E. F. (1998) · PubMed · Cited by 448
Koch, H. M., Drexler, H., & Angerer, J. (2003) · International Journal of Hygiene and Environmental Health · doi:10.1078/1438-4639-00205 · Cited by 432
Peroxisome Proliferator Activated Receptor-α Expression in Human Liver
Palmer, C. N. A., Hsu, M.-H., Griffin, K. J., Raucy, J. L., & Johnson, E. F. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.1.14 · Cited by 416
trans-Activation of PPARα and PPARγ by Structurally Diverse Environmental Chemicals
Maloney, E. K., & Waxman, D. J. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8809 · Cited by 374
Bursch, W., Lauer, B., Timmermann-Trosiener, I., Barthel, G., Schuppler, J., & Schulte-Hermann, R. (1984) · Carcinogenesis · doi:10.1093/carcin/5.4.453 · Cited by 362
Marsman, D. S., Cattley, R. C., Conway, J. G., & Popp, J. A. (1988) · PubMed · Cited by 353
Fan, C.-Y., Pan, J., Usuda, N., Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15639 · Cited by 343 · cited 2×
“, 1986); however, mice lacking this protein, instead of being protected from chemically induced liver cancer, develop liver tumors spontaneously, possibly as a result of a hyperactivation of PPARα by unmetabolized lipids (Fan et al., 1998).”
BackgroundKohli, V., Selzner, M., Madden, J. F., Bentley, R. C., & Clavien, P.-A. (1999) · Transplantation · doi:10.1097/00007890-199904270-00003 · Cited by 333
Reddy, J. K., Goel, S. K., Nemali, M. R., Carrino, J. J., Laffler, T. G., Reddy, M. K., Sperbeck, S. J., Osumi, T., Hashimoto, T., & Lalwani, N. D. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1747 · Cited by 324
Cytokine regulation of liver injury and repair
Diehl, A. M. (2000) · Immunological Reviews · doi:10.1034/j.1600-0528.2002.017411.x · Cited by 301
Vu-Dac, N., Chopin-Delannoy, S., Gervois, P., Bonnelye, E., Martin, G., Fruchart, J.-C., Laudet, V., & Staels, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25713 · Cited by 297
Mukherjee, R., Jow, L., Noonan, D., & McDonnell, D. P. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90089-2 · Cited by 270
The Toxicology of Ligands for Peroxisome Proliferator-Activated Receptors (PPAR)
Peraza, M. A., Burdick, A. D., Marin, H. E., Gonzalez, F. J., & Peters, J. M. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj062 · Cited by 254
Self-citationGlucuronidation patterns of common urinary and serum monoester phthalate metabolites
Silva, M. J., Barr, D. B., Reidy, J. A., Kato, K., Malek, N. A., Hodge, C. C., Hurtz, D., Calafat, A. M., Needham, L. L., & Brock, J. W. (2003) · Archives of Toxicology · doi:10.1007/s00204-003-0486-3 · Cited by 250
Ward, J. M., Peters, J. M., Perella, C. M., & Gonzalez, F. J. (1998) · Toxicologic Pathology · doi:10.1177/019262339802600208 · Cited by 249
Self-citationPeroxisome proliferator-activated receptor-α and liver cancer: where do we stand?
Peters, J. M., Cheung, C., & Gonzalez, F. J. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0678-9 · Cited by 248
Self-citationBility, M. T. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh253 · Cited by 231
Kasai, H., Okada, Y., Nishimura, S., Rao, M. S. R., & Reddy, J. K. (1989) · PubMed · Cited by 230
Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis
Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (2000) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(99)00234-1 · Cited by 225
Kroetz, D. L., Yook, P., Costet, P., Bianchi, P., & Pineau, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31581 · Cited by 219
Pharmacokinetics, interactions with macromolecules and species differences in metabolism of DEHP.
Albro, P. W., Corbett, J. T., Schroeder, J. L., Jordan, S., & Matthews, H. B. (1982) · Environmental Health Perspectives · doi:10.1289/ehp.824519 · Cited by 215
Cheung, C., Akiyama, T. E., Ward, J. M., Nicol, C. J., Feigenbaum, L., Vinson, C., & Gonzalez, F. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0322 · Cited by 215
Vu-Dac, N., Gervois, P., Jakel, H., Nowak, M., Baugé, E., Dehondt, H., Staels, B., Pennacchio, L. A., Rubin, E. M., Fruchart-Najib, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212191200 · Cited by 206
Studies on the hepatic effects of orally administered di-(2-ethylhexyl) phthalate in the rat
Lake, B. G., Gangolli, S. D., Grasso, P., & Lloyd, A. G. (1975) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(75)90226-4 · Cited by 201
Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis
Reddy, J. K., & Rao, M. S. (1989) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(89)90198-x · Cited by 193
Canitrot, Y., Cazaux, C., Fréchet, M., Bouayadi, K., Lesca, C., Salles, B., & Hoffmann, J.-S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12586 · Cited by 192
Aldridge, T. C., Tugwood, J. D., & Green, S. (1995) · Biochemical Journal · doi:10.1042/bj3060473 · Cited by 182
Jk, R., Rao, M. S. R., Dl, A., & Sell, S. (1979) · PubMed · Cited by 179
Vohl, M.-C., Lepage, P., Gaudet, D., Brewer, C. G., Bétard, C., Perron, P., Houde, G., Cellier, C., Faith, J. M., Després, J.-P., et al. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32037-x · Cited by 176
Mammalian peroxisomes and reactive oxygen species
Schrader, M., & Fahimi, H. D. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0673-1 · Cited by 176
Role of PPARα in mediating the effects of phthalates and metabolites in the liver
Lapinskas, P. J., Brown, S., Leesnitzer, L. M., Blanchard, S., Swanson, C., Cattley, R. C., & Corton, J. C. (2005) · Toxicology · doi:10.1016/j.tox.2004.09.008 · Cited by 173
Flavell, D. M., Torra, I. P., Jamshidi, Y., Evans, D., Diamond, J. R., Elkeles, R. S., Bujac, S. R., Miller, G., Talmud, P. J., Staels, B., et al. (2000) · Diabetologia · doi:10.1007/s001250051357 · Cited by 171
Morimura, K., Cheung, C., Ward, J. M., Reddy, J. K., & Gonzalez, F. J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi329 · Cited by 168
Excretion and metabolism of di(2-ethylhexyl)-phthalate in man
Schmid, P., & Schlatter, C. (1985) · Xenobiotica · doi:10.3109/00498258509045356 · Cited by 154
Reddy, J. K., Rao, M. S., & Moody, D. E. (1976) · PubMed · Cited by 152
Nemali, M. R., Usuda, N., Reddy, M. K., Oyasu, K., Hashimoto, T., Osumi, T., Rao, M. S., & Reddy, J. K. (1988) · PubMed · Cited by 148
Inherent increase of apoptosis in liver tumors: Implications for carcinogenesis and tumor regression
Grasl‐Kraupp, B., Ruttkay-Nedecký, B., Müllauer, L., Taper, H., Huber, W. W., Bursch, W., & Schulte‐Hermann, R. (1997) · Hepatology · doi:10.1002/hep.510250420 · Cited by 146
Role of Inhibition of Intercellular Communication in Carcinogenesis
Klaunig, J. E., & Ruch, R. J. (1990) · Humana Press eBooks · doi:10.1007/978-1-4612-0485-5_14 · Cited by 146
Effects of phthalic acid esters on the liver and thyroid.
Hinton, R. H., Mitchell, F. E., Mann, A., Chescoe, D., Price, S. C., Nunn, A., Grasso, P., & Bridges, J. W. (1986) · Environmental Health Perspectives · doi:10.1289/ehp.8670195 · Cited by 144
Hanefeld, M., Kemmer, C., & KADNER, E. (1983) · Atherosclerosis · doi:10.1016/0021-9150(83)90115-6 · Cited by 142
Gervois, P., Torra, I. P., Chinetti, G., Grötzinger, T., Dubois, G., Fruchart, J.-C., Fruchart-Najib, J., Leitersdorf, E., & Staels, B. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.9.0341 · Cited by 140
Reddy, J. K., Moody, D. E., Azarnoff, D. L., & Rao, M. S. R. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90412-4 · Cited by 140
Roberts, R. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.43 · Cited by 140
David, R. M. (1999) · Toxicological Sciences · doi:10.1093/toxsci/50.2.195 · Cited by 140
Rhodes, C. J., Orton, T. C., Pratt, I. S., Batten, P. L., Bratt, H., Jackson, S., & Elcombe, C. R. (1986) · Environmental Health Perspectives · doi:10.1289/ehp.8665299 · Cited by 135
Sapone, A., Peters, J. M., Sakai, S., Tomita, S., Papiha, S. S., Dai, R., Friedman, F. K., & Gonzalez, F. J. (2000) · Pharmacogenetics · doi:10.1097/00008571-200006000-00006 · Cited by 130
Self-citationHays, T. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh285 · Cited by 130
Peters, J. M., Rusyn, I., Rose, M. L., Gonzalez, F. J., & Thurman, R. G. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.823 · Cited by 129
Self-citationCattley, R. C., & Popp, J. A. (1989) · PubMed · Cited by 122
Peroxisome Proliferator–induced Pleiotropic Responses: Pursuit of a Phenomenona
Reddy, J. K., & Chu, R. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18616.x · Cited by 122
Time and dose-response study of the effects on rats of the plasticizer di(2-ethylhexyl) phthalate
Mitchell, F. E. (1985) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(85)90409-0 · Cited by 119
Conway, J. G., Tomaszewski, K. E., Olson, M. J., Cattley, R. C., Marsman, D. S., & Popp, J. A. (1989) · Carcinogenesis · doi:10.1093/carcin/10.3.513 · Cited by 118
Tumor-initiating and promoting activities of di(2-ethylhexyl) phthalate in vivo and in vitro.
Ward, J. M., Diwan, B. A., Ohshima, M., Hu, H., Schuller, H. M., & Rice, J. M. (1986) · Environmental Health Perspectives · doi:10.1289/ehp.8665279 · Cited by 116
Effects of Di-isononyl Phthalate, Di-2-ethylhexyl Phthalate, and Clofibrate in Cynomolgus Monkeys
Pugh, G. (2000) · Toxicological Sciences · doi:10.1093/toxsci/56.1.181 · Cited by 111
Sumanasekera, W. K., Tien, E. S., Turpey, R., Vanden Heuvel, J. P., & Perdew, G. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211261200 · Cited by 109
Woodyatt, N. J., Lambe, K. G., Myers, K. A., Tugwood, J. D., & Roberts, R. A. (1999) · Carcinogenesis · doi:10.1093/carcin/20.3.369 · Cited by 108
Central role of PPARα in the mechanism of action of hepatocarcinogenic peroxisome proliferators
Corton, J. C., Lapinskas, P. J., & Gonzalez, F. J. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(99)00232-8 · Cited by 107
Phthalate Esters and Their Effect on the Liver
Ganning, A. E., Brunk, U. T., & Dallner, G. (1984) · Hepatology · doi:10.1002/hep.1840040331 · Cited by 107
Mechanism of clofibrate hepatotoxicity: mitochondrial damage and oxidative stress in hepatocytes
Qu, B., Li, Q., Wong, K. P., Tan, T. M. C., & Halliwell, B. B. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00632-3 · Cited by 106
Absorption, metabolism, and excretion of di(2-ethylhexyl) phthalate by rats and mice.
Albro, P. W. (1986) · Environmental Health Perspectives · doi:10.1289/ehp.8665293 · Cited by 104
Evidence for a new human CYP1A1 regulation pathway involving PPAR-α and 2 PPRE sites
Sérée, E., Villard, P., Pascussi, J., Pineau, T., Maurel, P., N'Guyen, Q.-B., Fallone, F., Martin, P., Champion, S., Lacarelle, B., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.023 · Cited by 97
Rusyn, I., Asakura, S., Pachkowski, B., Bradford, B. U., Denissenko, M. F., Peters, J. M., Holland, S. M., Reddy, J. K., Cunningham, M. L., & Swenberg, J. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3027 · Cited by 97
Self-citationTakagi, A., Sai, K., Umemura, T., Hasegawa, R., & Kurokawa, Y. (1990) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1990.tb02551.x · Cited by 94
Phthalates Rapidly Increase Production of Reactive Oxygen Species in Vivo: Role of Kupffer Cells
Rusyn, I., Kadiiska, M. B., Dikalova, A., Kono, H., Yin, M., Tsuchiya, K., Mason, R. P., Peters, J. M., Gonzalez, F. J., Segal, B. H., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.4.744 · Cited by 94
Self-citationKupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators
Rose, M., Germolec, D. R., Schoonhoven, R., & Thurman, R. G. (1997) · Carcinogenesis · doi:10.1093/carcin/18.8.1453 · Cited by 92
Elliott, B. M., Dodd, N. J. F., & Elcombe, C. R. (1986) · Carcinogenesis · doi:10.1093/carcin/7.5.795 · Cited by 89
Cattley, R. C., Marsman, D. S., & Popp, J. A. (1991) · Carcinogenesis · doi:10.1093/carcin/12.3.469 · Cited by 88
Bojes, H. K., Germolec, D. R., Simeonova, P., Bruccoleri, A., Schoonhoven, R., Luster, M. I., & Thurman, R. G. (1997) · Carcinogenesis · doi:10.1093/carcin/18.4.669 · Cited by 87
Ito, Y., Yokota, H., Wang, R., Yamanoshita, O., Ichihara, G., Wang, H., Kurata, Y., Takagi, K., & Nakajima, T. (2004) · Archives of Toxicology · doi:10.1007/s00204-004-0615-7 · Cited by 87
Dirven, H. A. A. M., van den Broek, P. H. H., & JONGENEELEN, F. J. (1993) · International Archives of Occupational and Environmental Health · doi:10.1007/bf00517700 · Cited by 86
Kupffer cell oxidant production is central to the mechanism of peroxisome proliferators
Rose, M. L., Rivera, C. A., Bradford, B. U., Graves, L. M., Cattley, R. C., Schoonhoven, R., Swenberg, J. A., & Thurman, R. G. (1999) · Carcinogenesis · doi:10.1093/carcin/20.1.27 · Cited by 86
Lake, B. G., Kozlen, S. L., Evans, J. G., Gray, T. J. B., Young, P. J., & GANGOLLI, S. D. (1987) · Toxicology · doi:10.1016/0300-483x(87)90151-x · Cited by 85
WY-14 643 rapidly activates nuclear factor kappaB in Kupffer cells before hepatocytes
Rusyn, I. (1998) · Carcinogenesis · doi:10.1093/carcin/19.7.1217 · Cited by 82
Self-citationKurata, Y., Kidachi, F., Yokoyama, M., Toyota, N., Tsuchitani, M., & Katoh, M. (1998) · Toxicological Sciences · doi:10.1006/toxs.1997.2414 · Cited by 82
Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPARα
Roberts, R. A., James, N. H., Hasmall, S. C., Holden, P. R., Lambe, K. G., Macdonald, N., West, D., Woodyatt, N. J., & Whitcome, D. (2000) · Toxicology Letters · doi:10.1016/s0378-4274(99)00243-x · Cited by 80
ELLIOTT, B. M., & Elcombe, C. R. (1987) · Carcinogenesis · doi:10.1093/carcin/8.9.1213 · Cited by 79
Hasmall, S. C., James, N. H., Macdonald, N., Soames, A. R., & Roberts, R. A. (2000) · Archives of Toxicology · doi:10.1007/s002040050657 · Cited by 78
Sumanasekera, W. K., Tien, E. S., Davis, J. W., Turpey, R., Perdew, G. H., & Vanden Heuvel, J. P. (2003) · Biochemistry · doi:10.1021/bi0347353 · Cited by 78
Currie, R. A., Bombail, V., Oliver, J. D., Moore, D. J., Lim, F.-L., Gwilliam, V., Kimber, I., Chipman, K., Moggs, J. G., & Orphanides, G. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi207 · Cited by 78
Roberts, R. A. (1999) · Archives of Toxicology · doi:10.1007/s002040050629 · Cited by 74
Dirven, H. A. A. M., van den Broek, P. H. H., Arends, A. M. M., Nordkamp, H. H., de Lepper, A. J. G. M., Henderson, P. T., & JONGENEELEN, F. J. (1993) · International Archives of Occupational and Environmental Health · doi:10.1007/bf00517699 · Cited by 74
Hoivik, D. J., Qualls, C. W., Mirabile, R. C., Cariello, N. F., Kimbrough, C. L., Colton, H. M., Anderson, S. P., Santostefano, M. J., Morgan, R. J. O., Dahl, R. R., et al. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh182 · Cited by 73
Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans
Hertz, R., & Bar‐Tana, J. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00290-2 · Cited by 71
The effect of peroxisome proliferators on mitochondrial bioenergetics
Zhou, S., & Wallace, K. B. (1999) · Toxicological Sciences · doi:10.1093/toxsci/48.1.82 · Cited by 71
Biochemical studies on phthalic esters—II
Terue, T. (1977) · Biochemical Pharmacology · doi:10.1016/0006-2952(77)90124-1 · Cited by 70
Goll, V., Alexandre, E., Viollon‐Abadie, C., Nicod, L., Jaeck, D., & Richert, L. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8737 · Cited by 70
Ward, J. M., Hagiwara, A., Anderson, L. M., Lindsey, K. R., & Diwan, B. A. (1988) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(88)90009-9 · Cited by 68
Tanaka, A., Adachi, T., Takahashi, T., & Yamaha, T. (1975) · Toxicology · doi:10.1016/0300-483x(75)90105-5 · Cited by 67
Rose, M., Rusyn, I., Bojes, H. K., Belyea, J., Cattley, R. C., & Thurman, R. G. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(99)00235-3 · Cited by 62
Self-citationSuppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARα and TNFα
Hasmall, S. C., James, N. H., Macdonald, N., Gonzalez, F. J., Peters, J. M., & Roberts, R. A. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(99)00236-5 · Cited by 62
Self-citationNovel Role of Oxidants in the Molecular Mechanism of Action of Peroxisome Proliferators
Rusyn, I., Rose, M., Bojes, H. K., & Thurman, R. G. (2000) · Antioxidants and Redox Signaling · doi:10.1089/15230860050192350 · Cited by 61
Self-citationAtsdr Evaluation Of Health Effects Of Chemicals. Vi. Di(2-Ethylhexyl)Phthalate.
Fay, M., Donohue, J. M., & De Rosa, C. (1999) · Toxicology and Industrial Health · doi:10.1177/074823379901500801 · Cited by 61
Yu, S., Cao, W.-Q., Kashireddy, P., Meyer, K., Jia, Y., Hughes, D. E., Tan, Y., Feng, J., Yeldandi, A. V., Rao, M. S., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106480200 · Cited by 61
Morphometric study of human hepatic cell modifications induced by fenofibrate
Gariot, P., Barrat, E., Drouin, P., Genton, P., Pointel, J. P., Foliguet, B., Kolopp, M., & Debry, G. (1987) · Metabolism · doi:10.1016/0026-0495(87)90177-6 · Cited by 60
Peroxisome proliferators activate Kupffer cells in vivo.
Bojes, H. K., & Thurman, R. G. (1996) · PubMed · Cited by 58
Keller, B. J., Yamanaka, H., & Thurman, R. G. (1992) · Toxicology · doi:10.1016/0300-483x(92)90053-h · Cited by 57
Impaired Ras membrane association and activation in PPARα knockout mice after partial hepatectomy
Wheeler, M. D., Smutney, O. M., Check, J. F., Rusyn, I., Schulte-Hermann, R., & Thurman, R. G. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00175.2002 · Cited by 57
Self-citationIsenberg, J. S., Kamendulis, L. M., Smith, J. H., Ackley, D. C., Pugh, G., Lington, A. W., & Klaunig, J. E. (2000) · Toxicological Sciences · doi:10.1093/toxsci/56.1.73 · Cited by 55
Rusyn, I., Denissenko, M. F., Wong, V. A., Butterworth, B. E., Cunningham, M. L., Upton, P. B., Thurman, R. G., & Swenberg, J. A. (2000) · Carcinogenesis · doi:10.1093/carcin/21.12.2141 · Cited by 55
Self-citationSmith-Oliver, T. A., & Butterworth, B. E. (1987) · Mutation Research/Genetic Toxicology · doi:10.1016/0165-1218(87)90110-8 · Cited by 54
James, N. H., Soames, A. R., & Roberts, R. A. (1998) · Archives of Toxicology · doi:10.1007/s002040050574 · Cited by 54
Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b
Shipley, J. M., & Waxman, D. J. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.12.020 · Cited by 54
Rose, M., Germolec, D. R., Arteel, G. E., Schoonhoven, R., & Thurman, R. G. (1997) · Chemical Research in Toxicology · doi:10.1021/tx970079u · Cited by 51
Rusyn, I., Yamashina, S., Segal, B. H., Schoonhoven, R., Holland, S. M., Cattley, R. C., Swenberg, J. A., & Thurman, R. G. (2000) · PubMed · Cited by 48
Self-citationPeroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes
Parzefall, W., Berger, W., Kainzbauer, E., Teufelhofer, O., Schulte-Hermann, R., & Thurman, R. G. (2001) · Carcinogenesis · doi:10.1093/carcin/22.3.519 · Cited by 48
Hasmall, S. C., James, N. H., Macdonald, N., West, D., Chevalier, S., Cosulich, S. C., & Roberts, R. A. (1999) · Archives of Toxicology · doi:10.1007/s002040050634 · Cited by 46
Isenberg, J. S., Kamendulis, L. M., Ackley, D. C., Smith, J. H., Pugh, G., Lington, A. W., McKee, R. H., & Klaunig, J. E. (2001) · Toxicological Sciences · doi:10.1093/toxsci/64.2.192 · Cited by 45
Role of Kupffer cells in peroxisome proliferator-induced hepatocyte proliferation.
Rose, M. L., Rusyn, I., Bojes, H. K., Germolec, D., Luster, M., & Thurman, R. (1999) · Drug metabolism reviews (Softcover ed.) · doi:10.1081/dmr-100101909 · Cited by 44
Self-citationGill, J. H. (1998) · Carcinogenesis · doi:10.1093/carcin/19.2.299 · Cited by 44
PPAR alpha, fibrates, lipid metabolism and inflammation.
Duval, C., Fruchart, J., & Staels, B. (2004) · PubMed · Cited by 43
Handler, J. A., Seed, C. B., Bradford, B. U., & Thurman, R. G. (1992) · Toxicology Letters · doi:10.1016/0378-4274(92)90047-n · Cited by 42
Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver
Roglans, N. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.128605 · Cited by 41
Hepatic hyperplasia and cancer in rats: alterations in copper metabolism
Eagon, P. K., Teepe, A. G., Elm, M. S., Tadic, S. D., Epley, M. J., Beiler, B. E., Shinozuka, H., & Rao, K. N. (1999) · Carcinogenesis · doi:10.1093/carcin/20.6.1091 · Cited by 39
Hasmall, S. C. (2000) · Carcinogenesis · doi:10.1093/carcin/21.12.2159 · Cited by 39
Tumor necrosis factor alpha is not required for WY14,643-induced cell proliferation
Lawrence, J. W., Wollenberg, G. K., & DeLuca, J. G. (2001) · Carcinogenesis · doi:10.1093/carcin/22.3.381 · Cited by 38
Anderson, S. P., Dunn, C. S., Cattley, R. C., & Corton, J. C. (2001) · Carcinogenesis · doi:10.1093/carcin/22.11.1843 · Cited by 38
Effect of phthlate esters on energy coupling and succinate oxidation in rat liver mitochondria
Melnick, R. L., & Schiller, C. M. (1985) · Toxicology · doi:10.1016/0300-483x(85)90075-7 · Cited by 37
Lack of Peroxisome Proliferation in Marmoset Liver Following Treatment with Ciprofibrate for 3 Years
Graham, M. (1994) · Fundamental and Applied Toxicology · doi:10.1006/faat.1994.1008 · Cited by 35
PPAR?-dependent modulation of hepatic CYP1A by clofibric acid in rats
Shaban, Z., El-Shazly, S. A., Ishizuka, M., Kimura, K., Kazusaka, A., & Fujita, S. (2004) · Archives of Toxicology · doi:10.1007/s00204-004-0569-9 · Cited by 35
Ikeda, G. J., Sapienza, P. P., Couvillion, J. L., & Färber, T. M. (1980) · Food and Cosmetics Toxicology · doi:10.1016/s0015-6264(80)80012-5 · Cited by 34
Evidence against peroxisome proliferation-induced hepatic oxidative damage
Soliman, M. S., Cunningham, M. L., Morrow, J. D., Roberts, L. J., & Badr, M. Z. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)87956-7 · Cited by 28
Self-citationHasmall, S. C., James, N. H., Hedley, K., Olsen, K., & Roberts, R. A. (2001) · Archives of Toxicology · doi:10.1007/s002040100246 · Cited by 27
Role of cytokines in non-genotoxic hepatocarcinogenesis: cause or effect?
Roberts, R. A., James, N. H., Cosulich, S. C., Hasmall, S. C., & Orphanides, G. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00282-x · Cited by 22
Age-dependent effects of nongenotoxic hepatocarcinogens on liver apoptosis in vivo
Youssef, J., Bouziane, M., & Badr, M. Z. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00189-6 · Cited by 21
Grasl‐Kraupp, B., Huber, W., Just, W. W., Gibson, G., & Schulte‐Hermann, R. (1993) · Carcinogenesis · doi:10.1093/carcin/14.5.1007 · Cited by 20
Cell cross-talk mediates PPAR null hepatocyte proliferation after peroxisome proliferator exposure
Weglarz, T. C., & Sandgren, E. P. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg180 · Cited by 14
Nair, N., & Kurup, C. K. R. (1987) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(87)90199-1 · Cited by 13
Cited by
A Review of Biomonitoring of Phthalate Exposures
Wang, Y., Zhu, H., & Kannan, K. (2019) · Toxics · doi:10.3390/toxics7020021 · Cited by 822
Metabolism of phthalates in humans
Frederiksen, H., Skakkebaek, N. E., & Andersson, A. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200600243 · Cited by 652
Stahlhut, R. W., van Wijngaarden, E., Dye, T. D., Cook, S., & Swan, S. H. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.9882 · Cited by 646
Reproductive and Developmental Toxicity of Phthalates
Lyche, J. L., Gutleb, A. C., Bergman, Å., Eriksen, G. S., Murk, A. J., Ropstad, E., Saunders, M., & Skaare, J. U. (2009) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937400903094091 · Cited by 607
Endocrine disrupters as obesogens
Grün, F., & Blumberg, B. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.02.018 · Cited by 582
Metadata
- Authors
- Rusyn, I., Peters, J. M., & Cunningham, M. L.
- Venue
- Critical Reviews in Toxicology
- Publisher
- Informa UK Limited
- Published
- 2006-01
- Volume
- 36
- Issue
- 5
- Pages
- 459-479
- ISSN
- 0045-6446 (ISSN-L)
- 1040-8444
- 1547-6898
- OpenAlex
- W2096327556
- Cited by
- 301
- References
- 147
- FWCI
- 7.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.